# Pharmacokinetics of BIA 5-453 and Its Metabolites

> **NCT03090724** · PHASE1 · COMPLETED · sponsor: **Bial - Portela C S.A.** · enrollment: 25 (actual)

## Conditions studied

- Hypertension
- Chronic Heart Failure

## Interventions

- **DRUG:** BIA 5-453

## Key facts

- **NCT ID:** NCT03090724
- **Lead sponsor:** Bial - Portela C S.A.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2008-06-13
- **Primary completion:** 2008-08-12
- **Final completion:** 2008-08-12
- **Target enrollment:** 25 (ACTUAL)
- **Last updated:** 2017-03-27


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03090724

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03090724, "Pharmacokinetics of BIA 5-453 and Its Metabolites". Retrieved via AI Analytics 2026-06-08 from https://api.ai-analytics.org/clinical/NCT03090724. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*